0000908662-15-000114.txt : 20150306
0000908662-15-000114.hdr.sgml : 20150306
20150306161618
ACCESSION NUMBER: 0000908662-15-000114
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150305
FILED AS OF DATE: 20150306
DATE AS OF CHANGE: 20150306
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: DYAX CORP
CENTRAL INDEX KEY: 0000907562
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
IRS NUMBER: 043053198
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 55 NETWORK DRIVE
CITY: BURLINGTON
STATE: MA
ZIP: 01803-2756
BUSINESS PHONE: 617-250-5769
MAIL ADDRESS:
STREET 1: 55 NETWORK DRIVE
CITY: BURLINGTON
STATE: MA
ZIP: 01803-2756
FORMER COMPANY:
FORMER CONFORMED NAME: BIOTAGE INC
DATE OF NAME CHANGE: 19951117
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ADELMAN BURT A
CENTRAL INDEX KEY: 0001226283
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-24537
FILM NUMBER: 15681832
MAIL ADDRESS:
STREET 1: DYAX CORP.
STREET 2: 55 NETWORK DRIVE
CITY: BURLINGTON
STATE: MA
ZIP: 01803
4
1
edgar.xml
PRIMARY DOCUMENT
X0306
4
2015-03-05
0000907562
DYAX CORP
DYAX
0001226283
ADELMAN BURT A
C/O DYAX CORP.
55 NETWORK DRIVE
BURLINGTON
MA
01803-2756
0
1
0
0
CMO & EVP, R&D
Common Stock
2015-03-05
4
S
0
9375
15.6633
D
28125
D
The sales reported in this form 4 were effected pursuant to a Rule 10b5-1 trading plan. The sales were intended in part to provide liquidity sufficient to cover tax obligations due in connection with the vesting of restricted stock.
The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $15.40 to $16.09, inclusive. The reporting person undertakes to provide to Dyax Corp., any security holder of Dyax Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote 2.
/s/ Andrew D. Ashe, as attorney-in-fact
2015-03-06